Logo1 logo2
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Astec Lifesciences LtdIndustry : Pesticides / Agrochemicals - Indian
BSE Code:533138NSE Symbol: ASTECP/E(TTM):0
ISIN Demat:INE563J01010Div & Yield %:0EPS(TTM):0
Book Value(Rs):174.9630523Market Cap (rupee Cr.):1468.66Face Value(Rs):10
    Change Company 
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 448.15381.30458.18628.17676.57554.87
Excise Duty0.000.000.000.000.000.00
Net Sales448.15381.30458.18628.17676.57554.87
Other Income 4.995.565.5813.0410.467.67
Stock Adjustments -27.96-48.08-0.4659.5958.002.55
Total Income425.18338.78463.30700.80745.03565.09
EXPENDITURE :      
Raw Materials 270.45248.86318.82460.83444.82344.60
Power & Fuel Cost38.1634.0835.8745.6838.0425.28
Employee Cost 62.9161.1061.7452.2650.3138.35
Other Manufacturing Expenses 21.3222.5515.8116.4613.3711.70
Selling and Administration Expenses 20.6822.4320.9725.7623.5417.16
Miscellaneous Expenses 13.2710.4110.4210.5010.408.83
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure426.78399.42463.62611.49580.49445.92
Operating Profit-1.61-60.63-0.3289.30164.55119.18
Interest 34.5736.7125.2420.749.094.79
Gross Profit-36.18-97.34-25.5668.56155.46114.39
Depreciation44.9943.7736.3133.7134.4225.71
Profit Before Tax-81.17-141.11-61.8734.85121.0488.68
Tax0.000.000.000.0028.6124.59
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.16-6.31-14.899.332.61-0.61
Reported Net Profit-81.01-134.81-46.9925.5289.8264.69
Extraordinary Items -2.162.02-0.11-0.380.01-0.05
Adjusted Net Profit-78.85-136.83-46.8825.9089.8164.74
Adjst. below Net Profit 0.480.17-0.57-0.23-0.01-0.18
P & L Balance brought forward140.46275.10325.60303.25216.37154.79
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.002.942.942.942.94
P & L Balance carried down59.94140.46275.10325.60303.25216.37
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.0015.0015.0015.00
Earnings Per Share-Unit Curr-36.36-68.74-23.9613.0245.8333.03
Earnings Per Share(Adj)-Unit Curr-36.36-68.24-23.9613.0245.8333.03
Book Value-Unit Curr174.97119.36188.01213.61202.06157.60